News + Filings Transactions
|
Seehra Jasbir
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/15/2022 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Stock Options (Right to Buy) | 20k | $0.26 | $5.2k | | 06/15/2022 |
| 06/09/2022 | Keros Therapeutics, Inc. | KROS | Exercise | Employee Stock Option (right to buy) | 5k | $0.30 | $1.5k | | 06/09/2022 |
| 01/21/2022 | Keros Therapeutics, Inc. | KROS | Grant | Employee Stock Option (right to buy) | 165k | $46.30 | $7.6M | | 01/21/2022 |
| 05/19/2021 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Stock Option (Right to Buy) | 20k | $1.48 | $29.6k | | 05/19/2021 |
| 01/10/2021 | Keros Therapeutics, Inc. | KROS | Grant | Employee Stock Option (right to buy) | 127.2k | $70.93 | $9M | | 01/10/2021 |
| 05/20/2020 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Stock Option (Right to Buy) | 20k | $3.39 | $67.8k | | 05/20/2020 |
| 04/13/2020 | Keros Therapeutics, Inc. | KROS | Conversion | Series C Preferred Stock | 11.2k | $0.00 | $0 | | 04/13/2020 |
| 04/13/2020 | Keros Therapeutics, Inc. | KROS | Purchase | Common Stock | 20k | $16.00 | $320k | | 04/13/2020 |
| 04/13/2020 | Keros Therapeutics, Inc. | KROS | Conversion | Common Stock | 11.2k | $0.00 | $0 | | 04/13/2020 |
| 04/07/2020 | Keros Therapeutics, Inc. | KROS | Grant | Employee Stock Option (right to buy) | 696.6k | $16.00 | $11.1M | | 04/07/2020 |
| 05/29/2019 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Stock Option (Right to Buy) | 20k | $9.02 | $180.4k | | 05/29/2019 |
| 06/15/2018 | Eloxx Pharmaceuticals, Inc. | ELOX | Grant | Stock Option (Right to Buy) | 40k | $23.27 | $930.8k | | 06/15/2018 |
|